SEC Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): May 18, 2016
Quest Diagnostics Incorporated
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or other jurisdiction of Incorporation)
|
| | |
| | |
001-12215 | | 16-1387862 |
(Commission File Number)
| | (I.R.S. Employer Identification No.) |
| | |
Three Giralda Farms Madison, NJ 07940 | | 07940 |
(Address of principal executive offices) | | (Zip Code) |
| | |
(973) 520-2700 |
(Registrant’s telephone number, including area code) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
| |
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07 Submission of Matters to a Vote of Security Holders
(a) The following is a summary of the voting results for each matter presented to the stockholders at the 2016 Annual Meeting of Stockholders of Quest Diagnostics Incorporated (the "Company").
(b) The following nominees for the office of director were elected for terms expiring at the 2017 Annual Meeting of Stockholders, by the following votes:
|
| | | | | | | | | | | |
| | | | | | | |
| For | | Against | | Abstain | | Broker Non-Vote |
| | | | | | | |
Jenne K. Britell, Ph.D. | 114,431,441 |
| | 792,680 |
| | 379,605 |
| | 10,476,874 |
|
| | | | | | | |
Vicky B. Gregg | 112,348,232 |
| | 2,924,052 |
| | 331,442 |
| | 10,476,874 |
|
| | | | | | | |
Jeffrey M. Leiden, M.D., Ph.D. | 100,456,401 |
| | 14,774,919 |
| | 372,406 |
| | 10,476,874 |
|
| | | | | | | |
Timothy L. Main | 114,336,746 |
| | 888,261 |
| | 378,719 |
| | 10,476,874 |
|
| | | | | | | |
Gary M. Pfeiffer
| 113,818,690 |
| | 1,387,843 |
| | 397,193 |
| | 10,476,874 |
|
| | | | | | | |
Timothy M. Ring
| 112,014,861 |
| | 3,177,824 |
| | 411,041 |
| | 10,476,874 |
|
| | | | | | | |
Stephen H. Rusckowski | 113,745,572 |
| | 1,549,430 |
| | 308,724 |
| | 10,476,874 |
|
| | | | | | | |
Daniel C. Stanzione, Ph.D. | 112,847,627 |
| | 2,357,773 |
| | 398,326 |
| | 10,476,874 |
|
| | | | | | | |
Gail R. Wilensky, Ph.D. | 111,814,763 |
| | 2,180,128 |
| | 1,608,835 |
| | 10,476,874 |
|
| | | | | | | |
John B. Ziegler | 111,622,017 |
| | 2,375,255 |
| | 1,606,454 |
| | 10,476,874 |
|
The advisory resolution to approve the executive officer compensation disclosed in the Company's 2016 Proxy Statement was approved by the following votes:
|
| | | | | | |
For | | Against | | Abstain | | Broker Non-Vote |
105,703,456 | | 9,337,697 | | 562,573 | | 10,476,874 |
The ratification of the appointment of the Company's independent registered public accounting firm for 2016 was approved by the following votes:
|
| | | | | | |
For | | Against | | Abstain | | |
124,232,254 | | 1,605,124 | | 243,222 | | |
The amendments to the Company's Amended and Restated Employee Stock Purchase Plan was approved by the following votes:
|
| | | | | | |
For | | Against | | Abstain | | Broker Non-Vote |
113,551,769 | | 1,661,468 | | 390,489 | | 10,476,874 |
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
May 23, 2016
QUEST DIAGNOSTICS INCORPORATED
By: /s/ William J. O'Shaughnessy, Jr.
William J. O'Shaughnessy, Jr.
Deputy General Counsel and Secretary